Attomarker Seed
2 known investors
Attomarker develops a multiplexed blood testing platform that measures multiple biomarkers simultaneously and quantitatively, using gold particle nanotechnology, microfluidics and data analytics. Its tests, including a COVID Antibody Spectrum Test that classifies Long COVID immune endotypes, serve patients, clinicians, researchers and clinical partners for precision diagnostics and personalised medicine.
Deep TechDigital HealthMedical Devices
Investors Β· 2
Frequently asked questions
- What does Attomarker Seed do?
- Attomarker develops a multiplexed blood testing platform that measures multiple biomarkers simultaneously and quantitatively, using gold particle nanotechnology, microfluidics and data analytics. Its tests, including a COVID Antibody Spectrum Test that classifies Long COVID immune endotypes, serve patients, clinicians, researchers and clinical partners for precision diagnostics and personalised medicine.
- Who are Attomarker Seed's investors?
- Attomarker Seed's investors include Future Planet Capital, Milltrust International Group.